Style | Citing Format |
---|---|
MLA | Rezazadeh M, et al.. "Sustained-Release of Erythropoietin Using a Novel Injectable Thermosensitive Hydrogel: In Vitro Studies, Biological Activity, and Efficacy in Rats." Pharmaceutical Development and Technology, vol. 26, no. 4, 2021, pp. 412-421. |
APA | Rezazadeh M, Akbari V, Varshosaz J, Karbasizadeh P, Minaiyan M (2021). Sustained-Release of Erythropoietin Using a Novel Injectable Thermosensitive Hydrogel: In Vitro Studies, Biological Activity, and Efficacy in Rats. Pharmaceutical Development and Technology, 26(4), 412-421. |
Chicago | Rezazadeh M, Akbari V, Varshosaz J, Karbasizadeh P, Minaiyan M. "Sustained-Release of Erythropoietin Using a Novel Injectable Thermosensitive Hydrogel: In Vitro Studies, Biological Activity, and Efficacy in Rats." Pharmaceutical Development and Technology 26, no. 4 (2021): 412-421. |
Harvard | Rezazadeh M et al. (2021) 'Sustained-Release of Erythropoietin Using a Novel Injectable Thermosensitive Hydrogel: In Vitro Studies, Biological Activity, and Efficacy in Rats', Pharmaceutical Development and Technology, 26(4), pp. 412-421. |
Vancouver | Rezazadeh M, Akbari V, Varshosaz J, Karbasizadeh P, Minaiyan M. Sustained-Release of Erythropoietin Using a Novel Injectable Thermosensitive Hydrogel: In Vitro Studies, Biological Activity, and Efficacy in Rats. Pharmaceutical Development and Technology. 2021;26(4):412-421. |
BibTex | @article{ author = {Rezazadeh M and Akbari V and Varshosaz J and Karbasizadeh P and Minaiyan M}, title = {Sustained-Release of Erythropoietin Using a Novel Injectable Thermosensitive Hydrogel: In Vitro Studies, Biological Activity, and Efficacy in Rats}, journal = {Pharmaceutical Development and Technology}, volume = {26}, number = {4}, pages = {412-421}, year = {2021} } |
RIS | TY - JOUR AU - Rezazadeh M AU - Akbari V AU - Varshosaz J AU - Karbasizadeh P AU - Minaiyan M TI - Sustained-Release of Erythropoietin Using a Novel Injectable Thermosensitive Hydrogel: In Vitro Studies, Biological Activity, and Efficacy in Rats JO - Pharmaceutical Development and Technology VL - 26 IS - 4 SP - 412 EP - 421 PY - 2021 ER - |